Site icon pharmaceutical daily

Opioid Addiction Clinical Trial Pipeline Highlights 2019 – Forecast to 2024 by Clinical Stage, Drug Mechanism Classes, & Companies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Opioid Addiction Clinical Trial Pipeline Highlights – 2019”

report has been added to ResearchAndMarkets.com’s
offering.

Opioid Addiction Pipeline Highlights – 2019, provides most up-to-date
information on key pipeline products in the global Opioid Addiction
market.

It covers emerging therapies for Opioid Addiction in active clinical
development stages including early and late stage clinical trials. The
pipeline data presented in this report helps executives for tracking
competition, identifying partners, evaluating opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.

Clinical Trial Stages:

The report provides Opioid Addiction pipeline products by clinical trial
stages including both early and late stage development – phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Opioid Addiction pipeline products by their dominant
mechanism of action/drug class. This helps executives categorize
products based on their drug class and also assess the strengths and
weaknesses of compounds.

Company:

The report provides Opioid Addiction pipeline products by the company.

Short-term Launch Highlights:

Find out which Opioid Addiction pipeline products will be launched in
the US and Ex-US till 2024.

Key Topics Covered:

1. Opioid Addiction Pipeline by Stages

2. Opioid Addiction Phase 3 Clinical Trial Insights

3. Opioid Addiction Phase 2 Clinical Trial Insights

4. Opioid Addiction Phase 1 Clinical Trial Insights

5. Opioid Addiction Preclinical Research Insights

6. Opioid Addiction Discovery Stage Insights

7. Appendix

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/an2byr

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Related
Topics: Clinical
Trials
, Other
Healthcare Facilities
, Addiction
Disorders Drugs

Exit mobile version